NIDEK’s optical coherence tomography system-the RS-3000 Advance-has received FDA clearance.
Fremont, CA-NIDEK’s optical coherence tomography system-the RS-3000 Advance-has received FDA clearance.
The imaging system, which incorporates a scanning laser ophthalmoscope, is designed for comprehensive evaluation of the retina and choroid. The product also provides detail of the retinal and chorodial microstructures to assist in clinical diagnosis.
“We are pleased to have this clearance, and confident the results reflect the quality of our diagnostic tools in imaging that assist doctors in diagnosing ocular diseases,” said Motoki Ozawa, president of NIDEK.
For more articles in this issue of Ophthalmology Times eReport, click here.
To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.